| A 6-month, placebo-controlled study comparing lung function and health status changes in COPD patients treated with tiotropium or salmeterol JF Donohue, JA van Noord, ED Bateman, SJ Langley, A Lee, TJ Witek Jr, ... Chest 122 (1), 47-55, 2002 | 727 | 2002 |
| Improvement in exercise tolerance with the combination of tiotropium and pulmonary rehabilitation in patients with COPD R Casaburi, D Kukafka, CB Cooper, TJ Witek Jr, S Kesten Chest 127 (3), 809-817, 2005 | 595 | 2005 |
| Tiotropium (Spiriva™): mechanistical considerations and clinical profile in obstructive lung disease B Disse, GA Speck, KL Rominger, TJ Witek Jr, R Hammer Life sciences 64 (6-7), 457-464, 1999 | 445 | 1999 |
| Frequency and natural history of rhinovirus infections in adults during autumn E Arruda, A Pitkäranta, TJ Witek Jr, CA Doyle, FG Hayden Journal of clinical microbiology 35 (11), 2864-2868, 1997 | 429 | 1997 |
| Long-acting bronchodilation with once-daily dosing of tiotropium (Spiriva) in stable chronic obstructive pulmonary disease MR Littner, JS Ilowite, DP Tashkin, M Friedman, CW Serby, SS Menjoge, ... American journal of respiratory and critical care medicine 161 (4), 1136-1142, 2000 | 339 | 2000 |
| The spirometric efficacy of once-daily dosing with tiotropium in stable COPD: a 13-week multicenter trial R Casaburi, DD Briggs Jr, JF Donohue, CW Serby, SS Menjoge, ... Chest 118 (5), 1294-1302, 2000 | 316 | 2000 |
| Pharmacoeconomic evaluation of a combination of ipratropium plus albuterol compared with ipratropium alone and albuterol alone in COPD M Friedman, CW Serby, SS Menjoge, JD Wilson, DE Hilleman, TJ Witek Jr Chest 115 (3), 635-641, 1999 | 258 | 1999 |
| The effects of tiotropium bromide on the circadian variation in airflow limitation in chronic obstructive pulmonary disease KS Calverly P, Lee A, Towse L, Witek TJ Thorax 58, 855-860, 2003 | 203 | 2003 |
| The MCID of the transition dyspnea index is a total score of one unit DA Mahler, TJ Witek Jr COPD: Journal of Chronic Obstructive Pulmonary Disease 2 (1), 99-103, 2005 | 188 | 2005 |
| Effective delivery of particles with the HandiHaler® dry powder inhalation system over a range of chronic obstructive pulmonary disease severity S Chodosh, JS Flanders, S Kesten, CW Serby, D Hochrainer, TJ Witek Jr Journal of aerosol medicine 14 (3), 309-315, 2001 | 159 | 2001 |
| The combination of ipratropium and albuterol optimizes pulmonary function reversibility testing in patients with COPD PM Dorinsky, C Reisner, GT Ferguson, SS Menjoge, CW Serby, ... Chest 115 (4), 966-971, 1999 | 134 | 1999 |
| Meaningful effect size and patterns of response of the transition dyspnea index TJ Witek Jr, DA Mahler Journal of clinical epidemiology 56 (3), 248-255, 2003 | 98 | 2003 |
| A Ten.){ear Follow-up Study of Cotton Textile Workers1-3 E Zuskin, D Ivankovic, EN Schachter, TJ Witek Jr Am Rev Respir Dis 143, 301-5, 1991 | 87 | 1991 |
| An evaluation of respiratory effects following exposure to 2.0 ppm formaldehyde in asthmatics: lung function, symptoms, and airway reactivity. TJ Witek Jr, EN Schachter, T Tosun, GJ Beck, BP Leaderer Archives of Environmental Health 42 (4), 230-237, 1987 | 82 | 1987 |
| Analysis of inhaled corticosteroid and oral theophylline use among patients with stable COPD from 1987 to 1995 AE Van Andel, C Reisner, SS Menjoge, TJ Witek Chest 115 (3), 703-707, 1999 | 76 | 1999 |
| Characterization of daytime sleepiness and psychomotor performance following H1 receptor antagonists. TJ Witek Jr, DA Canestrari, RD Miller, JY Yang, DK Riker Annals of allergy, asthma & immunology: official publication of the American …, 1995 | 71 | 1995 |
| The e-cigarette or vaping product use–associated lung injury epidemic: pathogenesis, management, and future directions: an official American Thoracic Society Workshop Report ME Rebuli, JJ Rose, A Noël, DP Croft, NL Benowitz, AH Cohen, ... Annals of the American Thoracic Society 20 (1), 1-17, 2023 | 60 | 2023 |
| The shape of the maximum expiratory flow volume curve MC Kapp, EN Schachter, GJ Beck, LR Maunder, TJ Witek Jr Chest 94 (4), 799-806, 1988 | 57 | 1988 |
| A study of respiratory effects from exposure to 2 ppm formaldehyde in healthy subjects EN Schachter, TJ Witek Jr, T Tosun, BP Leaderer, GJ Beck Archives of Environmental Health: An International Journal 41 (4), 229-239, 1986 | 57 | 1986 |
| A study of respiratory effects from exposure to 2.0 ppm formaldehyde in occupationally exposed workers EN Schachter, TJ Witek Jr, DJ Brody, T Tosun, GJ Beck, BP Leaderer Environmental Research 44 (2), 188-205, 1987 | 43 | 1987 |
Richard CasaburiLos Angeles Biomedical Research Institute at Harbor-UCLA Medical Center在 ucla.edu 的电子邮件经过验证
